Kyverna Therapeutics


Kyverna is a cell therapy company engineering and developing a new class of curative living medicines for inflammatory and autoimmune diseases.

Employees

11-50

Links


Org chart

Warner Biddle
Chief Executive Officer
Collapse
David Moriarty
Vice President Clinical Operations
Dominic Borie
President, Research & Development
John Farris
Vp, Head Of Gxp Quality
Tom Van Blarcom
SVP & Head, Research
Wyatt Luenenborg
Commercial Vice President
Tracy Rossin
Senior Vice President, Corporate Affairs, Communications And Investor Relations
Cara Bauer
Chief Human Resources Officer
Julia Winter
V.p. Corporate Development

Board & advisors

Ian Clark
Chairman
Brian Kotzin
Director
Fred Cohen
Director
Steve Liapis
Director
Georg Schett
Scientific Advisor
Peter A. Merkel
Scientific Advisor
Ignacio Sanz
Scientific Advisor